Holland C Detke

5PUBLICATIONS
3CO-AUTHORS
GlycoconjugatesTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 29, 2023
Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE-1 and EVOLVE-2.

E Anne MacGregor, Rose Okonkwo, Holland C Detke

|Feb 16, 2023
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study.

Richard B Lipton, Dawn C Buse, Claire H Sandoe

|Aug 16, 2022
Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN).

Joshua A Tobin, Shivang Joshi, Janet H Ford

|Apr 08, 2022
Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study.

Patricia Pozo-Rosich, Holland C Detke, Shufang Wang

|Sep 20, 2021
Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial.

Uwe Reuter, Christian Lucas, David Dolezil

Pageof 1

Frequent Collaborators

1 joint publications

Janet H Ford

1 joint publications

Martha D Port

1 joint publications

E Anne MacGregor